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Increasing The Odds For Cancer Survival
Conquering cancer, the nation's second leading cause of death, is a high priority in the United States. Although the federal government's "war on cancer," declared in 1971, has proven to be an intractable battle, statisticians continue to report that the number of people diagnosed as having cancer who then survive is increasing. 1 Experts predict that data scheduled for release at the end of 1984 will show the five-year survival rates for cancer surpassing 50 percent for the first time. The most promising improvements in survivability have come among children afflicted with cancer.
These statistics, however, are subject to different interpretations, as 7% New York Timtes reported September 18 in an article entitled, "Cancer Progress: Are the Statistics Telling the Truth?" Reporter Phillip M. Boffey canvassed the views of researchers, some of whom argue that cancer survival statistics show inflated gains in the war against cancer. These analysts claim that the statistics have been manipulated to show artificial progress by three main factors: (1) diagnosis techniques have improved to the point where tumors are being diagnosed today that have the characteristics of cancer and are included in the cancer counts, but which actually would not result in death, thereby increasing the survival counts; (2) earlier detection of cancer shows more people with some forms of cancer (particularly breast cancer) who appear to survive five years after diagnosis since the diagnosis was determined at an earlier point in the cancer's development; and (3) improvements in recording nonfatal cancer cases as compared to cancer deaths may also be a factor in the increasing survival rates. Vincent T. DeVita, director of the National Cancer Institute discounts the skeptics' claims, saying in the Times article, "I think it's a bunch of nonsense. We're saving thousands of lives today that weren't saved twenty years ago. To me, that's pretty damn exciting." Although other leaders in the cancer field acknowledge some validity to these claims, they assert that the error in the reported statistics is not so great as to reverse the charted trends.
A combination of increased funding and improved research efforts, stemming in part from enactment of the National Cancer Act of 1971, and some key discoveries about cancer genes through recombinant DNA technologies, have led to the improvements-in cancer survival rates. Congress increased appropriations for the National Cancer Institute (NCI) from $230 million in 1971 to $1 billion by 1980. 2 The number of medical oncologists practicing in the United States increased from 100 in the late 1960s to about 2,800 by 1980.
3 Dr. Henry C. Pitot, chairman of the National Cancer Advisory Board, has noted that, "Improved cancer survival rates, and decreases in cancer deaths for patients under age forty-five, occurred in part because of the community-based oncologists who see many can- The rapidity of progress in solving the mysteries of cancer has surprised even optimistic members of the research community. Lewis Thomas, President Emeritus of the Memorial Sloan-Kettering Cancer Center, recently wrote in Health Affairs: "In the late 1960s if any young post-doctoral student or M.D. had asked me about the advisability of going into cancer research, my advice would have been to stay away, and instead to pick a field such as immunology or molecular biology, in which things are clearly moving along. . . . And then, still in the early 1970s things began to change at a great rate, and they have been changing with stunning speed ever since. . . . Cancer is beginning to look like an approachable problem, even (although at this point everyone tends to speak softly) a soluble problem." Exhibit 2 documents the wide range of survival rates for the various types of cancers. For some major cancers, such as breast, prostate, melanoma, and testis, more than two-thirds of the patient population is expected to survive five years after diagnosis. The five-year mark is a generally accepted indicator of curability. Except for cancers of the breast, prostate, and kidney, most patients who survive five years after being diagnosed as having cancer are considered cured. The SEER rates are calculated by an actuarial, or life-table, method and thus include information on patients observed for less than five years. A complete five-year follow-up was conducted for those patients diagnosed during the years 1973 to 76. The survival rates released in November 1983 were revised upward because patients diagnosed in 1980 were included and an additional year of follow-up was completed -1981.
As shown in Exhibit 1, the survival rates for black cancer patients lag considerably behind those of whites. Exhibit 3 breaks down the sur- viva1 rates for a number of major cancers for patients diagnosed during 1973-80.
One of the major success stories in cancer, however, has been the great improvement in survivability for children with cancer. Exhibit 4 charts the upward trends for a variety of children's cancers. Dr. Guilio D'Angio, Director of the Cancer Center at Children's Hospital of Philadelphia has said, "Now more than half of the children with a variety of cancers can expect to live a normal life free of disease."
6 Advances in surgical techniques and radiation therapy in combination with new cancer drugs, or chemotherapy, have fueled the increases in cures for childhood cancer victims. Fine-tuning to decrease the side effects of cancer treatments is still needed, though.
Many of cancer's mysteries remain unsolved, and a glimpse at some cancer mortality data shows higher death rates. Data released in September 1983 in U.S. Cancer Mortality Rates and Trends: 1950-1979 by the Environmental Protection Agency and NCI indicate that total cancer death rates have increased slightly over the past three decades, up 16 percent for white males and 39 percent for nonwhite males. For females, mortality rates fell slightly for whites and changed negligibly for non- whites. Mortality rates. for lung cancer have shown the most sizeable increases, 116 percent for white males, 199 percent for white females, and 185 and 188 percent for nonwhite males and females, respectively.
7
The increases in lung cancer mortality rates for women are particularly alarming. Exhibit 5 shows these increases of the past fifteen years as compared to breast cancer. By the end of 1984, lung cancer is expected to surpass breast cancer as the leader of cancer deaths in women, according to NCI statisticians. Also, two researchers working with the SEER program reported in The Journal of the National Cancer Institute that the total incidence rates of lung cancer for women may even equal that of men by the year 2000, if current trends continue. 
